A unifying model of the immunoregulatory role of the interferon system: Can interferon produce disease in humans?
This hypothesis is a presentation of a unifying model of the interferon (IFN) system as a cascade of sequentially interacting responses of IFNs-α, -β, and -γ involved in modulation of the immune response. We propose that every antigen is an IFNogen. The first stage(s) of immune responsiveness is ass...
Gespeichert in:
Veröffentlicht in: | Clinical immunology and immunopathology 1987-06, Vol.43 (3), p.362-373 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 373 |
---|---|
container_issue | 3 |
container_start_page | 362 |
container_title | Clinical immunology and immunopathology |
container_volume | 43 |
creator | Skurkovich, S. Skurkovich, B. Bellanti, J.A. |
description | This hypothesis is a presentation of a unifying model of the interferon (IFN) system as a cascade of sequentially interacting responses of IFNs-α, -β, and -γ involved in modulation of the immune response. We propose that every antigen is an IFNogen. The first stage(s) of immune responsiveness is associated primarily with the production of the family of IFN-α. In certain immunologically mediated diseases, including the autoimmune diseases and AIDS, disturbances in the synthesis of IFN-α occur with a switch to the production of predominantly acid-labile types, which have a negative immunoregulatory effect. Moreover, disturbances of IFN synthesis in the embryo or fetus can lead to deformities. Some viruses and other biological and chemical substances manifest a pathological effect by the IFN they induce. This IFN may help sustain the viruses and other substances which induce this IFN. We think it is unsafe to give patients immunoregulators in incomplete form. Thus, there is a potential danger in giving patients recombinant forms of IFNs and interleukin 2 produced in bacteria. In certain immune disorders, we may be able to treat patients by the binding or removal of hyperproduced IFNs from the body. This may lead to the restoration of immunologic balance and clinical improvement. |
doi_str_mv | 10.1016/0090-1229(87)90146-2 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_14907518</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0090122987901462</els_id><sourcerecordid>14907518</sourcerecordid><originalsourceid>FETCH-LOGICAL-c417t-449ca3ff6187a1298a1dce2b660191c676cdf9ddded22b578452c9f7377cb32f3</originalsourceid><addsrcrecordid>eNp9kM1qGzEURkVISd0kb5CCFiE0i2kkjTySumgwpn9gyCZZC1m6ihVmJEeaKfjtO1Mbk1VWgvud7-pyELqi5CsltLkjRJGKMqa-SHGrCOVNxU7QjE5jVnN6imZH5CP6VMoLIaThRJyhM8ZrSUQ9Q68LPMTgdyE-4y45aHHyuN8ADl03xJTheWhNn_IO59TCMYw9ZA85RVx2pYfuG16a-Ha8zckNFrALBUyZGngzdCaW-wv0wZu2wOXhPUdPP388Ln9Xq4dff5aLVWU5FX3FubKm9r6hUhjKlDTUWWDrpiFUUduIxjqvnHPgGFvPheRzZpUXtRB2XTNfn6Ob_d7xlNcBSq-7UCy0rYmQhqIpV0TMqRxBvgdtTqVk8HqbQ2fyTlOiJ9N60qgnjVoK_d-0ZmPt82H_sO7AHUsHtWN-fchNsab12UQbyhGTTHKlpt-_7zEYXfwNkHWxAaIFFzLYXrsU3r_jHwygmzs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>14907518</pqid></control><display><type>article</type><title>A unifying model of the immunoregulatory role of the interferon system: Can interferon produce disease in humans?</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Skurkovich, S. ; Skurkovich, B. ; Bellanti, J.A.</creator><creatorcontrib>Skurkovich, S. ; Skurkovich, B. ; Bellanti, J.A.</creatorcontrib><description>This hypothesis is a presentation of a unifying model of the interferon (IFN) system as a cascade of sequentially interacting responses of IFNs-α, -β, and -γ involved in modulation of the immune response. We propose that every antigen is an IFNogen. The first stage(s) of immune responsiveness is associated primarily with the production of the family of IFN-α. In certain immunologically mediated diseases, including the autoimmune diseases and AIDS, disturbances in the synthesis of IFN-α occur with a switch to the production of predominantly acid-labile types, which have a negative immunoregulatory effect. Moreover, disturbances of IFN synthesis in the embryo or fetus can lead to deformities. Some viruses and other biological and chemical substances manifest a pathological effect by the IFN they induce. This IFN may help sustain the viruses and other substances which induce this IFN. We think it is unsafe to give patients immunoregulators in incomplete form. Thus, there is a potential danger in giving patients recombinant forms of IFNs and interleukin 2 produced in bacteria. In certain immune disorders, we may be able to treat patients by the binding or removal of hyperproduced IFNs from the body. This may lead to the restoration of immunologic balance and clinical improvement.</description><identifier>ISSN: 0090-1229</identifier><identifier>EISSN: 1090-2341</identifier><identifier>DOI: 10.1016/0090-1229(87)90146-2</identifier><identifier>PMID: 2438073</identifier><identifier>CODEN: CLIIAT</identifier><language>eng</language><publisher>San Diego, CA: Elsevier Inc</publisher><subject>Antibody Formation ; Autoimmune Diseases - immunology ; Biological and medical sciences ; Fundamental and applied biological sciences. Psychology ; Genetics ; Humans ; Immunocompetence ; Interferon Type I - adverse effects ; Interferon Type I - biosynthesis ; Interferon Type I - immunology ; Interferons - immunology ; Interleukin-2 - adverse effects ; Microbiology ; Nephritis, Interstitial - chemically induced ; Recombinant Proteins - adverse effects ; T-Lymphocytes - immunology ; Virology</subject><ispartof>Clinical immunology and immunopathology, 1987-06, Vol.43 (3), p.362-373</ispartof><rights>1987</rights><rights>1987 INIST-CNRS</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c417t-449ca3ff6187a1298a1dce2b660191c676cdf9ddded22b578452c9f7377cb32f3</citedby><cites>FETCH-LOGICAL-c417t-449ca3ff6187a1298a1dce2b660191c676cdf9ddded22b578452c9f7377cb32f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=8284998$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2438073$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Skurkovich, S.</creatorcontrib><creatorcontrib>Skurkovich, B.</creatorcontrib><creatorcontrib>Bellanti, J.A.</creatorcontrib><title>A unifying model of the immunoregulatory role of the interferon system: Can interferon produce disease in humans?</title><title>Clinical immunology and immunopathology</title><addtitle>Clin Immunol Immunopathol</addtitle><description>This hypothesis is a presentation of a unifying model of the interferon (IFN) system as a cascade of sequentially interacting responses of IFNs-α, -β, and -γ involved in modulation of the immune response. We propose that every antigen is an IFNogen. The first stage(s) of immune responsiveness is associated primarily with the production of the family of IFN-α. In certain immunologically mediated diseases, including the autoimmune diseases and AIDS, disturbances in the synthesis of IFN-α occur with a switch to the production of predominantly acid-labile types, which have a negative immunoregulatory effect. Moreover, disturbances of IFN synthesis in the embryo or fetus can lead to deformities. Some viruses and other biological and chemical substances manifest a pathological effect by the IFN they induce. This IFN may help sustain the viruses and other substances which induce this IFN. We think it is unsafe to give patients immunoregulators in incomplete form. Thus, there is a potential danger in giving patients recombinant forms of IFNs and interleukin 2 produced in bacteria. In certain immune disorders, we may be able to treat patients by the binding or removal of hyperproduced IFNs from the body. This may lead to the restoration of immunologic balance and clinical improvement.</description><subject>Antibody Formation</subject><subject>Autoimmune Diseases - immunology</subject><subject>Biological and medical sciences</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Genetics</subject><subject>Humans</subject><subject>Immunocompetence</subject><subject>Interferon Type I - adverse effects</subject><subject>Interferon Type I - biosynthesis</subject><subject>Interferon Type I - immunology</subject><subject>Interferons - immunology</subject><subject>Interleukin-2 - adverse effects</subject><subject>Microbiology</subject><subject>Nephritis, Interstitial - chemically induced</subject><subject>Recombinant Proteins - adverse effects</subject><subject>T-Lymphocytes - immunology</subject><subject>Virology</subject><issn>0090-1229</issn><issn>1090-2341</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1987</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kM1qGzEURkVISd0kb5CCFiE0i2kkjTySumgwpn9gyCZZC1m6ihVmJEeaKfjtO1Mbk1VWgvud7-pyELqi5CsltLkjRJGKMqa-SHGrCOVNxU7QjE5jVnN6imZH5CP6VMoLIaThRJyhM8ZrSUQ9Q68LPMTgdyE-4y45aHHyuN8ADl03xJTheWhNn_IO59TCMYw9ZA85RVx2pYfuG16a-Ha8zckNFrALBUyZGngzdCaW-wv0wZu2wOXhPUdPP388Ln9Xq4dff5aLVWU5FX3FubKm9r6hUhjKlDTUWWDrpiFUUduIxjqvnHPgGFvPheRzZpUXtRB2XTNfn6Ob_d7xlNcBSq-7UCy0rYmQhqIpV0TMqRxBvgdtTqVk8HqbQ2fyTlOiJ9N60qgnjVoK_d-0ZmPt82H_sO7AHUsHtWN-fchNsab12UQbyhGTTHKlpt-_7zEYXfwNkHWxAaIFFzLYXrsU3r_jHwygmzs</recordid><startdate>19870601</startdate><enddate>19870601</enddate><creator>Skurkovich, S.</creator><creator>Skurkovich, B.</creator><creator>Bellanti, J.A.</creator><general>Elsevier Inc</general><general>Academic Press</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope></search><sort><creationdate>19870601</creationdate><title>A unifying model of the immunoregulatory role of the interferon system: Can interferon produce disease in humans?</title><author>Skurkovich, S. ; Skurkovich, B. ; Bellanti, J.A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c417t-449ca3ff6187a1298a1dce2b660191c676cdf9ddded22b578452c9f7377cb32f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1987</creationdate><topic>Antibody Formation</topic><topic>Autoimmune Diseases - immunology</topic><topic>Biological and medical sciences</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Genetics</topic><topic>Humans</topic><topic>Immunocompetence</topic><topic>Interferon Type I - adverse effects</topic><topic>Interferon Type I - biosynthesis</topic><topic>Interferon Type I - immunology</topic><topic>Interferons - immunology</topic><topic>Interleukin-2 - adverse effects</topic><topic>Microbiology</topic><topic>Nephritis, Interstitial - chemically induced</topic><topic>Recombinant Proteins - adverse effects</topic><topic>T-Lymphocytes - immunology</topic><topic>Virology</topic><toplevel>online_resources</toplevel><creatorcontrib>Skurkovich, S.</creatorcontrib><creatorcontrib>Skurkovich, B.</creatorcontrib><creatorcontrib>Bellanti, J.A.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Clinical immunology and immunopathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Skurkovich, S.</au><au>Skurkovich, B.</au><au>Bellanti, J.A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A unifying model of the immunoregulatory role of the interferon system: Can interferon produce disease in humans?</atitle><jtitle>Clinical immunology and immunopathology</jtitle><addtitle>Clin Immunol Immunopathol</addtitle><date>1987-06-01</date><risdate>1987</risdate><volume>43</volume><issue>3</issue><spage>362</spage><epage>373</epage><pages>362-373</pages><issn>0090-1229</issn><eissn>1090-2341</eissn><coden>CLIIAT</coden><abstract>This hypothesis is a presentation of a unifying model of the interferon (IFN) system as a cascade of sequentially interacting responses of IFNs-α, -β, and -γ involved in modulation of the immune response. We propose that every antigen is an IFNogen. The first stage(s) of immune responsiveness is associated primarily with the production of the family of IFN-α. In certain immunologically mediated diseases, including the autoimmune diseases and AIDS, disturbances in the synthesis of IFN-α occur with a switch to the production of predominantly acid-labile types, which have a negative immunoregulatory effect. Moreover, disturbances of IFN synthesis in the embryo or fetus can lead to deformities. Some viruses and other biological and chemical substances manifest a pathological effect by the IFN they induce. This IFN may help sustain the viruses and other substances which induce this IFN. We think it is unsafe to give patients immunoregulators in incomplete form. Thus, there is a potential danger in giving patients recombinant forms of IFNs and interleukin 2 produced in bacteria. In certain immune disorders, we may be able to treat patients by the binding or removal of hyperproduced IFNs from the body. This may lead to the restoration of immunologic balance and clinical improvement.</abstract><cop>San Diego, CA</cop><cop>New York, NY</cop><cop>Boston</cop><pub>Elsevier Inc</pub><pmid>2438073</pmid><doi>10.1016/0090-1229(87)90146-2</doi><tpages>12</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0090-1229 |
ispartof | Clinical immunology and immunopathology, 1987-06, Vol.43 (3), p.362-373 |
issn | 0090-1229 1090-2341 |
language | eng |
recordid | cdi_proquest_miscellaneous_14907518 |
source | MEDLINE; Alma/SFX Local Collection |
subjects | Antibody Formation Autoimmune Diseases - immunology Biological and medical sciences Fundamental and applied biological sciences. Psychology Genetics Humans Immunocompetence Interferon Type I - adverse effects Interferon Type I - biosynthesis Interferon Type I - immunology Interferons - immunology Interleukin-2 - adverse effects Microbiology Nephritis, Interstitial - chemically induced Recombinant Proteins - adverse effects T-Lymphocytes - immunology Virology |
title | A unifying model of the immunoregulatory role of the interferon system: Can interferon produce disease in humans? |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T21%3A25%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20unifying%20model%20of%20the%20immunoregulatory%20role%20of%20the%20interferon%20system:%20Can%20interferon%20produce%20disease%20in%20humans?&rft.jtitle=Clinical%20immunology%20and%20immunopathology&rft.au=Skurkovich,%20S.&rft.date=1987-06-01&rft.volume=43&rft.issue=3&rft.spage=362&rft.epage=373&rft.pages=362-373&rft.issn=0090-1229&rft.eissn=1090-2341&rft.coden=CLIIAT&rft_id=info:doi/10.1016/0090-1229(87)90146-2&rft_dat=%3Cproquest_cross%3E14907518%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=14907518&rft_id=info:pmid/2438073&rft_els_id=0090122987901462&rfr_iscdi=true |